Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonathan Kay

Showing results (161-170 of 172) with videos related to

Pageof 18
Sort By:
The Prostate|August 4, 2018
Immunohistochemical biomarker validation in highly selective needle biopsy microarrays derived from mpMRI-characterized prostatesJonathan Olivier, Vasilis Stavrinides, Jonathan Kay, et al.
Clinical and Translational Science|January 27, 2021
Pharmacokinetic equivalence of CT-P17 to high-concentration (100 mg/ml) reference adalimumab: A randomized phase I study in healthy subjectsKyung-Sang Yu, In-Jin Jang, Hyeong-Seok Lim, et al.
Medrxiv : the Preprint Server for Health Sciences|February 27, 2026
Longitudinal peripheral blood multi-omic profiling in seropositive individuals identifies immune endotypes and predictive models for future rheumatoid arthritis conversionJun Inamo, Aleksandra Bylinska, Miles Smith, et al.
Oncotarget|October 13, 2016
HNF1B variants associate with promoter methylation and regulate gene networks activated in prostate and ovarian cancerHelen Ross-Adams, Stephen Ball, Kate Lawrenson, et al.
Molecular Cancer|September 21, 2022
The architecture of clonal expansions in morphologically normal tissue from cancerous and non-cancerous prostatesClaudia Buhigas, Anne Y Warren, Wing-Kit Leung, et al.
Arthritis and Rheumatism|September 28, 2010
2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiativeDaniel Aletaha, Tuhina Neogi, Alan J Silman, et al.
Annals of the Rheumatic Diseases|August 12, 2010
2010 rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiativeDaniel Aletaha, Tuhina Neogi, Alan J Silman, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|August 30, 2025
A phase 2 trial of hydroxychloroquine in individuals at risk for rheumatoid arthritisKevin D Deane, Christopher C Striebich, Marie L Feser, et al.
Arthritis and Rheumatism|September 28, 2010
The 2010 American College of Rheumatology/European League Against Rheumatism classification criteria for rheumatoid arthritis: Phase 2 methodological reportTuhina Neogi, Daniel Aletaha, Alan J Silman, et al.
Nature Genetics|March 3, 2015
Analysis of the genetic phylogeny of multifocal prostate cancer identifies multiple independent clonal expansions in neoplastic and morphologically normal prostate tissueColin S Cooper, Rosalind Eeles, David C Wedge, et al.
Pageof 18

Showing results (161-170 of 172) with videos related to

Sort By:
Pageof 18
The Prostate|August 4, 2018
Immunohistochemical biomarker validation in highly selective needle biopsy microarrays derived from mpMRI-characterized prostatesJonathan Olivier, Vasilis Stavrinides, Jonathan Kay, et al.
Clinical and Translational Science|January 27, 2021
Pharmacokinetic equivalence of CT-P17 to high-concentration (100 mg/ml) reference adalimumab: A randomized phase I study in healthy subjectsKyung-Sang Yu, In-Jin Jang, Hyeong-Seok Lim, et al.
Medrxiv : the Preprint Server for Health Sciences|February 27, 2026
Longitudinal peripheral blood multi-omic profiling in seropositive individuals identifies immune endotypes and predictive models for future rheumatoid arthritis conversionJun Inamo, Aleksandra Bylinska, Miles Smith, et al.
Oncotarget|October 13, 2016
HNF1B variants associate with promoter methylation and regulate gene networks activated in prostate and ovarian cancerHelen Ross-Adams, Stephen Ball, Kate Lawrenson, et al.
Molecular Cancer|September 21, 2022
The architecture of clonal expansions in morphologically normal tissue from cancerous and non-cancerous prostatesClaudia Buhigas, Anne Y Warren, Wing-Kit Leung, et al.
Arthritis and Rheumatism|September 28, 2010
2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiativeDaniel Aletaha, Tuhina Neogi, Alan J Silman, et al.
Annals of the Rheumatic Diseases|August 12, 2010
2010 rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiativeDaniel Aletaha, Tuhina Neogi, Alan J Silman, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|August 30, 2025
A phase 2 trial of hydroxychloroquine in individuals at risk for rheumatoid arthritisKevin D Deane, Christopher C Striebich, Marie L Feser, et al.
Arthritis and Rheumatism|September 28, 2010
The 2010 American College of Rheumatology/European League Against Rheumatism classification criteria for rheumatoid arthritis: Phase 2 methodological reportTuhina Neogi, Daniel Aletaha, Alan J Silman, et al.
Nature Genetics|March 3, 2015
Analysis of the genetic phylogeny of multifocal prostate cancer identifies multiple independent clonal expansions in neoplastic and morphologically normal prostate tissueColin S Cooper, Rosalind Eeles, David C Wedge, et al.
Pageof 18